Výsledky vyhledávání - Cinzia Finocchi
- Zobrazuji výsledky 1 - 12 z 12
-
1
Cut‐Off Values Able to Identify Migraine Patients With Increased Pressure‐Pain Sensitivity Independent of the Migraine Cycle Through a Single Assessment: A Secondary Analysis of a... Autor Matteo Castaldo, Lars Arendt‐Nielsen, Marta Ponzano, Francesca Bovis, Paola Torelli, Cinzia Finocchi, Stefano Di Antonio
Vydáno 2025Artigo -
2
Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke Autor A. Mattioni, Silvia Cenciarelli, Paolo Eusebi, Miriam Brazzelli, Tatiana Mazzoli, Massimo Del Sette, Claudia Gandolfo, Marinella Marinoni, Cinzia Finocchi, Valentina Saia, Stefano Ricci
Vydáno 2020Revisão -
3
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study Autor Piero Barbanti, Cinzia Aurilia, Paola Torelli, Gabriella Egeo, Florindo d’Onofrio, Cinzia Finocchi, Antonio Carnevale, Giovanna Viticchi, Marco Russo, Simone Quintana, Bianca Orlando, Giulia Fiorentini, Roberta Messina, Marco Bartolini, Francesca Pistoia, Massimo Filippi, Stefano Bonassi, Sabina Cevoli, Alice Mannocci
Vydáno 2025Artigo -
4
Anti-Rituximab antibodies Occurrence and Clinical Outcomes in patients with Primary Membranous Nephropathy Autor Marco Allinovi, Maxime Teisseyre, Matteo Accinno, Cinzia Finocchi, Vincent Esnault, Marion Crémoni, Tommaso Mazzierli, Daniela Lazzarini, Micaela Anna Casiraghi, Céline Fernandez, Kévin Zorzi, Vesna Brglez, Lorenzo Cosmi, Andrea Matucci, Leonardo Caroti, Giulia Antognoli, Calogero Lino Cirami, Alessandra Vultaggio, Barbara Seitz‐Polski
Vydáno 2025Artigo -
5
Maintenance of response and predictive factors of 1‐year <scp>GalcanezumAb</scp> treatment in real‐life migraine patients in <scp>Italy</scp>: The multicenter prospective cohort <s... Autor Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Renata Rao, Luigi d’Onofrio, Cinzia Finocchi, Marco Aguggia, Francesco Bono, Angelo Ranieri, Maria Albanese, Vittorio Di Piero, Sabina Cevoli, Claudia Altamura, Piero Barbanti
Vydáno 2022Artigo -
6
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) Autor Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Giulia Pierangeli, Carlo Lovati, Marco Aguggia, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Renata Rao, Francesco Bono, Angelo Ranieri, Maria Albanese, Sabina Cevoli, Piero Barbanti
Vydáno 2021Artigo -
7
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients Autor Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Vydáno 2022Artigo -
8
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study Autor Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Paola Torelli, Marco Aguggia, Davide Bertuzzo, Cinzia Finocchi, Michele Trimboli, Sabina Cevoli, Giulia Fiorentini, Bianca Orlando, Maurizio Zucco, Laura Di Clemente, Ilaria Cetta, Bruno Colombo, Monica Laura Bandettini di Poggio, Valentina Favoni, Licia Grazzi, Antonio Salerno, Antonio Carnevale, Micaela Robotti, Fabio Frediani, Claudia Altamura, Massimo Filippi, Fabrizio Vernieri, Stefano Bonassi
Vydáno 2024Artigo -
9
Late Response to Anti-CGRP Monoclonal Antibodies in Migraine Autor Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Paola Torelli, Stefania Proietti, Sabina Cevoli, Stefano Bonassi, Giulia Fiorentini Psy, Roberta Messina, Bruno Colombo, Florindo d’Onofrio, Maria Albanese, Cinzia Finocchi, Antonio Salerno, B. Mercuri, Antonio Carnevale, Francesco Bono, Fabio Frediani, Licia Grazzi, Domenico D’Amico, Massimo Filippi, Claudia Altamura, Fabrizio Vernieri, Marco Aguggia, Davide Bertuzzo, Maurizio Zucco, Laura Di Clemente, Michele Trimboli, Valentina Favoni, Paola Di Fiore
Vydáno 2023Artigo -
10
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study Autor Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Cinzia Aurilia, Cinzia Finocchi, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina, Massimo Autunno, Angelo Ranieri, Antonio Carnevale, Bruno Colombo, Massimo Filippi, Miriam Tasillo, Steno Rinalduzzi, Pietro Querzani, Giuliano Sette, Lorenzo Forino, Francesco Zoroddu, Micaela Robotti, Alessandro Valenza, Cecilia Camarda, L. Borrello, Marco Aguggia, Giovanna Viticchi, Carlo Tomino, Giulia Fiorentini, Bianca Orlando, Stefano Bonassi, Paola Torelli
Vydáno 2024Artigo -
11
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experi... Autor Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Francesca Schiano di Cola, Florindo d’Onofrio, Cinzia Finocchi, Davide Bertuzzo, Francesco Bono, Angelo Ranieri, Maria Albanese, Roberta Messina, Alberto Doretti, Vittorio Di Piero, Sabina Cevoli, Piero Barbanti, Fabrizio Vernieri, Carmelina Maria Costa, Luisa Fofi, Renata Rao, Luigi d’Onofrio, Daniele Spitalieri, Marco Aguggia, Fabio Bombardieri, Bruno Colombo, Massimo Filippi, Stefano Messina, Gianluca Demirtzidis
Vydáno 2022Artigo -
12
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study Autor Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Paola Torelli, Cinzia Finocchi, Florindo d’Onofrio, Luigi d’Onofrio, Renata Rao, Stefano Messina, Laura Di Clemente, Angelo Ranieri, Massimo Autunno, Giuliano Sette, Bruno Colombo, Antonio Carnevale, Marco Aguggia, Miriam Tasillo, Francesco Zoroddu, Fabio Frediani, Massimo Filippi, Carlo Tomino, Stefania Proietti, Stefano Bonassi, Maria Albanese, Marco Bertolini, Davide Bertuzzo, Maria Bloise, Francesco Bono, L. Borrello, Cecilia Camarda, Giulia Fiorentini, Licia Grazzi, Domenica Le Pera, Roberta Messina, Pietro Querzani, Antonio Salerno, Silvia Strumia, Alessandro Valenza, Fabrizio Vernieri, Giovanna Viticchi
Vydáno 2023Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Migraine
Chronic Migraine
Adverse effect
Antibody
Clinical endpoint
Immunology
Neurology
Prospective cohort study
Psychiatry
Tolerability
Calcitonin gene-related peptide
Clinical trial
Cohort
Monoclonal antibody
Neuropeptide
Observational study
Randomized controlled trial
Receptor
Anesthesia
Calcitonin
Cohort study
Multicenter study
Neuroradiology
Pathology
Pediatrics
Acute stroke
Analgesic
Body mass index